Sayson, Judito, JR.. S.
HRN: 25-25-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
MUPIROCIN 2%, 15G (TUBE)
06/07/2024
06/14/2024
TOPICAL
15g
BID
Soft Tissue Injury Sec To MVA
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes